Select a filter to view information.
Unable to generate insights at this time.
| Ticker | Security Name ⇅ | PrevClose | Beta | MarketCap | PE Ratio ⇅ | Dividend Yield | PBV Ratio ⇅ | Category |
|---|---|---|---|---|---|---|---|---|
| ANANTRAJ | Anant Raj Ltd. | 621.0 | 1.016 | 16771.467 | 41.322 | 0.002 | 4.211 | Mid-Cap |
| CGCL | Capri Global Capital Ltd. | 192.1 | 0.306 | 13125.966 | 33.256 | 0.001 | 3.143 | Mid-Cap |
| ASTRAZEN | Astrazeneca Pharma India Ltd. | 9178.5 | 0.434 | 19188.844 | 191.205 | 0.003 | 27.144 | Mid-Cap |
| CHOICEIN | Choice International Ltd. | 819.0 | 0.376 | 9596.442 | 62.893 | 0.0 | 10.351 | Mid-Cap |
| KRN | KRN Heat Exchanger And Refrigeration Ltd. | 833.9 | 0.0 | 5774.35 | 141.443 | 0.0 | 11.091 | Mid-Cap |
| CCL | CCL Products (India) Ltd. | 835.25 | 0.609 | 7616.44 | 26.774 | 0.008 | 4.033 | Mid-Cap |
| ASTRAMICRO | Astra Microwave Products Ltd. | 1081.2 | 1.073 | 5916.031 | 42.517 | 0.003 | 5.797 | Mid-Cap |
| CENTURYPLY | Century Plyboards (India) Ltd. | 751.4 | 0.969 | 15684.282 | 71.174 | 0.001 | 6.679 | Mid-Cap |
| AURIONPRO | Aurionpro Solutions Ltd. | 1169.9 | 0.775 | 7208.391 | 38.373 | 0.001 | 4.928 | Mid-Cap |
| ALKYLAMINE | Alkyl Amines Chemicals Ltd. | 1923.9 | 0.933 | 8315.731 | 44.924 | 0.006 | 6.091 | Mid-Cap |
Select a filter to view information.
No information available.
No information available.
No information available.
No information available.
No information available.
No information available.
No information available.
No information available.
No information available.
No information available.
It depicts the actual and verifiable returns generated by the portfolios of SEBI registered entities. Live performance does not include any backtested data or claim and does not guarantee future returns.
By proceeding, you understand that investments are subjected to market risks and agree that returns shown on the platform were not used as an advertisement or promotion to influence your investment decisions.
"I was drawn to Wright Research due to its multi-factor approach. Their Balanced MFT is an excellent product."
By Prashant Sharma
CTO, Zydus
By signing up, you agree to our Terms and Privacy Policy
"I was drawn to Wright Research due to its multi-factor approach. Their Balanced MFT is an excellent product."
By Prashant Sharma
CTO, Zydus
Skip Password
By signing up, you agree to our Terms and Privacy Policy
"I was drawn to Wright Research due to its multi-factor approach. Their Balanced MFT is an excellent product."
By Prashant Sharma
CTO, Zydus
"I was drawn to Wright Research due to its multi-factor approach. Their Balanced MFT is an excellent product."
By Prashant Sharma
CTO, Zydus
Log in with Password →
By logging in, you agree to our Terms and Privacy Policy
"I was drawn to Wright Research due to its multi-factor approach. Their Balanced MFT is an excellent product."
By Prashant Sharma
CTO, Zydus
Log in with OTP →
By logging in, you agree to our Terms and Privacy Policy
"I was drawn to Wright Research due to its multi-factor approach. Their Balanced MFT is an excellent product."
By Prashant Sharma
CTO, Zydus
Answer these questions to get a personalized portfolio or skip to see trending portfolios.
Answer these questions to get a personalized portfolio or skip to see trending portfolios.
(You can choose multiple options)
Answer these questions to get a personalized portfolio or skip to see trending portfolios.
Answer these questions to get a personalized portfolio or skip to see trending portfolios.
Answer these questions to get a personalized portfolio or skip to see trending portfolios.
(You can choose multiple options)
Investor Profile Score
We've tailored Portfolio Management services for your profile.
View Recommended Portfolios Restart
